Cliff Stocks: Founder and CEO of OncoResponse
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.